News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
South African core lab adopts Affymetrix technology for genomic studies

.

Santa Clara, California
October 8, 2008

Centre for Proteomic and Genomic Research aims to become the country's hub for microarray-based research

Affymetrix Inc. (Nasdaq:AFFX) today announced that one of South Africa's largest public core labs has begun offering genomic research on the Affymetrix GeneChip(R) platform. The Centre for Proteomic and Genomic Research (CPGR) is using many Affymetrix GeneChip arrays, such as the exon array and the SNP Array 6.0, to explore applications with molecular diagnostics potential, large-scale genotyping and novel ways of advancing drug research and development across the country.

The CPGR supports scientists particularly in biomedicine and plant biotechnology. It has a particular interest in translational research, advancing scientific findings from the bench into the clinic. The Centre was founded in 2006 to provide state-of-the-art analytical services, technical expertise, project support and collaborative research capabilities in genomics and proteomics.

"At the CPGR, our aim is to facilitate high-quality research and enable the growth of existing southern African biotech companies," said Reinhard Hiller, Ph.D., managing director of the CPGR. "The range of projects we work on is particularly diverse, so we appreciate the ability of Affymetrix to offer products that meet all our customers' needs, from toxicology to gene expression and genotyping."

"The CPGR has assembled a team of world-class scientists to nourish the development of new biotech leaders by translating academic research into novel intellectual property and commercial ventures," said Kevin King, president of Affymetrix. "With its adoption of the entire portfolio of array products available on our integrated microarray platform, the Centre is setting new standards for microarray-based research which we believe will lead to important solutions for some of the region's most pressing diseases."

Affymetrix GeneChip(R) microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research and enable scientists to develop diagnostics and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases.

Today, Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutes. More than 1,700 systems have been shipped around the world and more than 13,000 peer-reviewed papers have been published using the technology.


Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Sacramento, Calif., Cleveland, Ohio, and Singapore. The company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit the company's website at www.affymetrix.com.

The Centre for Proteomic & Genomic Research (CPGR) is an integrated core technology facility, founded in South Africa in 2006 as a not-for-profit organization through a grant provided by the Department of Science and Technology (DST) by way of its vehicles the Cape Biotech Trust CBT) and PlantBio (PB). Visit www.cpgr.org.za for more information or contact info@cpgr.org.za with specific requests.

Affymetrix, the Affymetrix logo and GeneChip(R) are registered trademarks owned or used by Affymetrix Inc.

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved